Guardant Health Inc · Transaction Nov 21, 2025 · Filed Dec 1, 2025 · $1,001 to $15,000
XNAS · GH
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Guardant Health, Inc. Common Stock
SERVICES-MEDICAL LABORATORIES
$161.67
Veridion Score
BETALOW CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · GH
MethodologyGH
Guardant Health, Inc. Common Stock
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is GH moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Guardant Health, Inc. Common Stock
SERVICES-MEDICAL LABORATORIESListed since
2018
Employees
3K
Country
US
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$161.67
Last session
Day high
$161.67
Last session
Day low
$161.67
Last session
Previous close
$161.67
52W high
$170.77
-5.33% from high
52W low
$54.79
92% of range
Market cap
$21.1B
EPS
$-3.3200
Beta
1.38
Shares out
134.2M
Avg volume
2.2M
VWAP
$161.67
Last session
Price history computed in-house
1W
-2.07%
1M
+3.72%
3M
+40.62%
1Y
+171.85%
YTD
+58.28%
SMA 50 $150.15 · above
SMA 200 $112.49 · above
52W position 92%
GH overview
Related filings and maps
Public disclosures
Congress activity in GH
Official filing ↗
GH Common Stock · Transaction Feb 28, 2022 · Filed Mar 3, 2022 · Amount pending receipt enrichment
GH Common Stock · Transaction Jan 13, 2022 · Filed Feb 1, 2022 · Amount pending receipt enrichment
GH Common Stock · Transaction Dec 22, 2021 · Filed Jan 1, 2022 · Amount pending receipt enrichment
GH Common Stock · Transaction Nov 2, 2020 · Filed Dec 1, 2020 · Amount pending receipt enrichment
Federal contracts
GH contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GH in this window.
Lobbying spend
GH lobbying filings, year to date.
Registered lobbying filings matched to Guardant Health, Inc. Common Stock.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GH in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for GH.
Options
Sovereign unlock shows live options positioning for GH.